- Home
- ADXN vs PSTV Comparison
ADXN vs PSTV Comparison
Compare ADXN & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- PSTV
- Stock Information
- Founded
- ADXN 2002
- PSTV 1996
- Country
- ADXN Switzerland
- PSTV United States
- Employees
- ADXN N/A
- PSTV N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- PSTV Medical/Dental Instruments
- Sector
- ADXN Health Care
- PSTV Health Care
- Exchange
- ADXN Nasdaq
- PSTV Nasdaq
- Market Cap
- ADXN 8.5M
- PSTV 6.3M
- IPO Year
- ADXN N/A
- PSTV N/A
- Fundamental
- Price
- ADXN $7.79
- PSTV $0.98
- Analyst Decision
- ADXN Strong Buy
- PSTV Strong Buy
- Analyst Count
- ADXN 1
- PSTV 2
- Target Price
- ADXN $30.00
- PSTV $13.50
- AVG Volume (30 Days)
- ADXN 45.6K
- PSTV 85.5K
- Earning Date
- ADXN 11-22-2024
- PSTV 11-14-2024
- Dividend Yield
- ADXN N/A
- PSTV N/A
- EPS Growth
- ADXN N/A
- PSTV N/A
- EPS
- ADXN 0.06
- PSTV N/A
- Revenue
- ADXN $701,260.00
- PSTV $5,725,000.00
- Revenue This Year
- ADXN N/A
- PSTV $39.96
- Revenue Next Year
- ADXN N/A
- PSTV N/A
- P/E Ratio
- ADXN $1.05
- PSTV N/A
- Revenue Growth
- ADXN N/A
- PSTV 52.63
- 52 Week Low
- ADXN $5.39
- PSTV $0.98
- 52 Week High
- ADXN $27.90
- PSTV $2.67
- Technical
- Relative Strength Index (RSI)
- ADXN 42.74
- PSTV 28.29
- Support Level
- ADXN $7.14
- PSTV $1.31
- Resistance Level
- ADXN $8.40
- PSTV $1.37
- Average True Range (ATR)
- ADXN 0.62
- PSTV 0.10
- MACD
- ADXN 0.07
- PSTV -0.03
- Stochastic Oscillator
- ADXN 27.39
- PSTV 0.00
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).